Clinical Evidence
Discover the clinical performance of Assert-IQ Insertable Cardiac Monitor (ICM) with our latest real-world evidence on battery longevity. This cutting-edge cardiac monitor generates clinically actionable data that matters for physicians and patients.
Explore our featured presentations and publications to learn how Assert-IQ ICM can enhance patient care with its proven effectiveness in diagnosing and managing cardiac arrhythmias.
Atrial Fibrillation Detection Performance of the Assert-IQ ICM: Results from an Assert-IQ Post-Market Clinical Study and a Novel Artificial Intelligence Algorithm (2025)
Results from a prospective, multicenter post-market study demonstrated that the Assert‑IQ ICM accurately detected atrial fibrillation with 100% patient-level sensitivity and strong AF burden correlation to Holter monitoring. The study also showed that a novel AI algorithm reduced false-positive AF episodes while maintaining high detection performance.
Precision in Cardiac Monitoring: Leading the Way With Insertable Cardiac Monitors (2025)
A video series by Dhanunjaya (DJ) Lakkireddy, MD with Raffaele De Lucia, MD
View a discussion on the durability and effectiveness of ICMs and their impact on post-procedure monitoring, high-risk atrial fibrillation (AF) populations and long-term patient management.
Watch the webinar series here:
Value of Dynamic Long-term Monitoring for Chronic Arrhythmia Management (2024)
Presentation at Heart Rhythm 2024 by Dhanunjaya (DJ) Lakkireddy, MD
Learn how long-term monitoring with an ICM can improve access to care, early intervention, and ongoing decision-making for atrial fibrillation patients to achieve better outcomes.
Watch the presentation here:
Insertable Cardiac Monitoring Results in Higher Rates of Atrial Fibrillation Diagnosis and Oral Anticoagulation Prescription after Ischaemic Stroke (2023)
Real-world clinical evidence from a U.S. nationwide study shows that insertable cardiac monitoring results in higher rates of atrial fibrillation (AF) diagnosis and oral anticoagulation implementation compared to external cardiac monitoring after cryptogenic stroke (CS). Patients with ICMs were almost 3 times more likely to be diagnosed with AF and to be prescribed an OAC compared to patients who only received an ECM.2
Novel Algorithms Improve Arrhythmia Detection Accuracy in Insertable Cardiac Monitors (2023)
This article from the Journal of Cardiovascular Electrophysiology, is a retrospective analysis using episodes triggered by real‐world ICM devices to develop and evaluate new discrimination algorithms that further reduce false detections of atrial fibrillation (AF), pause, and tachycardia episodes in Abbott's next-generation ICM system. The evaluation showed that newly developed algorithms substantially reduced false episodes while having minimal impact on true ones, as compared to the predicate Abbott ICM algorithms. Implementation of the enhanced algorithms in an ICM system may lead to improved detection accuracy, device clinic efficiency, and longer battery longevity.3
Stay Informed
Sign up to hear about our technology, education opportunities, and more.
Read the Latest Blog Article
Stay up to date with recent news, product highlights, and case studies.
References:
- Birgersdotter-Green U, Ojeda W, Manyam H, et al. Atrial Fibrillation Detection Performance of the Assert-IQ Insertable Cardiac Monitor: Results from an Assert-IQ Post-Market Clinical Study and a Novel Artificial Intelligence Algorithm. Heart Rhythm O2. November 11, 2025; DOI: https://doi.org/10.1016/j.hroo.2025.10.021
- Boriani G, Auricchio A, Botto GL, et al. Insertable Cardiac Monitoring Results in Higher Rates of Atrial Fibrillation Diagnosis and Oral Anticoagulation Prescription after Ischaemic Stroke. EP Europace. 2023; euad212, doi.org/10.1093/europace/euad212.
- Gopinathannair R, Shehata MM, Afzal MR, et al. Novel Algorithms Improve Arrhythmia Detection Accuracy in Insertable Cardiac Monitors. Journal of Cardiovascular Electrophysiology. July 2023. doi:10.1111/jce.16007.
MAT-2607974 v10.0